Since its inception in 2003 BioCarta LLC has been a leader in the fields of signal pathway reporting and immunoreagents. In 2014 Allele Biotechnology acquired BioCarta, their reputation within the immunodiagnostic field was a natural fit with the emergence of our new nano-antibody reagent line (nAb™). Immunodiagnostics harnesses antibody-antigen reactions as a means to quantitatively detect compounds of interest, even if they are present in miniscule amounts. The kits offered under our immunodiagnostic line are convenient, reliable, and ready-to-use. Looking forward, by utilizing our nAb™ line we will offer a wide array of reagents and tools for the immunodiagnostic field.
For the past 11 years BioCarta has been the exclusive US and Canadian distributor of Immune Function Assay Kits for Flow Cytometric Analysis produced by Glycotope Biotechnology, GmbH. These kits are based on flow cytometry procedures for fast, precise measurement of various cell functions focused on the functional and quantitative characterization of the cellular immune response. These kits are clinically approved blood cell diagnostic assay products, and they are widely used in both clinical and non-clinical settings.
Each kit is a complete, ready-to-use reagent kit with all the approriate materials to carry out their respective assays. All the components are fully validated and each kit comes with a simple, precise protocol. Glycotope Immunodiagnostic kits are known for their unimpeachable lot to lot quality and a high degree of consistency.